Cannabis Business Financial Report: Page 6

Cannabis Sale-Leaseback Activity Muted in Q1 2023

The market for sale-leasebacks has been affected by broader industry headwinds, though there may be signs for cautious optimism.

Trulieve, Verano, Ascend Wellness Buckle Up for New Growth Markets

Reporting first quarter financials, CEOs from the three multistate operators are now regearing for more favorable business conditions.

Curaleaf’s Boris Jordan Says New Super PAC Will Sway SAFE Banking’s Passage in 2023

The company’s executive chairman provided a timeline for the bill during an earnings call but said he’s not “predicting anything in Washington.”

Curaleaf to Restate Certain Previously Issued 2022 and 2021 Financial Statements

The company will report minor reductions in revenue of approximately 1.25% and 0.75% for 2021 and 2022, respectively.

Verano CEO Says 2023 Will Be ‘Inflection Point’ for Cannabis Industry

As smaller operators struggle to weather the industry downturn, George Archos forecasts favorable M&A deals in attractive markets.

Trulieve CEO Sets Goal of $100 Million in Operating Cash Flow This Year

Stomping onward with the nation’s largest cannabis retail footprint, Trulieve reported $1.2 billion in revenue for 2022.

Green Thumb CEO Warns of ‘Washout’ for Cannabis Industry

The company reported $1 billion in revenue for 2022 with a net income of $12 million on a GAAP basis.

Tilray Brands Reports Second Quarter Fiscal Year 2023 Financial Results

The company achieved $29.2 million of operating cash flow and $25.4 million of free cash flow.

Verano Announces 3Q 2022 Financial Results

The company’s third quarter 2022 revenue increased 2% versus the prior quarter and 10% year-over-year to $228 million.

Verano Bets $5 Million to Enter Virginia Medical Market

The multistate cannabis operator entered into an agreement to acquire MedMen’s PhamaCann Virginia LLC, which has a license tied up in litigation.

Ayr Wellness Reports Second Quarter 2022 Results

The vertically integrated U.S. multistate cannabis operator, is reporting financial results for the three months ended June 30, 2022.

Cresco Labs Announces Second Quarter 2022 Results

Company reports 4% year-over-year revenue growth and 11% year-over-year adjusted EBITDA growth; continues industry leadership with branded product performance and retail productivity.

Previous Page

Page 6 of 8

Next Page